Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma

Abstract

MDM2 was expressed in 26% of HCC, and its expression correlated positively with p53 mutations. MDM2 over-expression is a useful predictor of poor prognosis in patients with HCC following hepatic resection.